Who owns the SOLUTIONS FOR ACCELERATED DRUG DEVELOPMENT trademark?

The SOLUTIONS FOR ACCELERATED DRUG DEVELOPMENT trademark is owned by Ilex Oncology, Inc..

What class is the SOLUTIONS FOR ACCELERATED DRUG DEVELOPMENT trademark registered in?

The SOLUTIONS FOR ACCELERATED DRUG DEVELOPMENT trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for SOLUTIONS FOR ACCELERATED DRUG DEVELOPMENT?

The USPTO serial number for SOLUTIONS FOR ACCELERATED DRUG DEVELOPMENT is 75235807.

What is the registration number for SOLUTIONS FOR ACCELERATED DRUG DEVELOPMENT?

SOLUTIONS FOR ACCELERATED DRUG DEVELOPMENT is registered under USPTO registration number 2129014.

SOL

USPTO Trademark Record

ABANDONED

SOLUTIONS FOR ACCELERATED DRUG DEVELOPMENT

SN 75235807·Reg 2129014·Filed Feb 03, 1997

Owner Ilex Oncology, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

SOLUTIONS FOR ACCELERATED DRUG DEVELOPMENT (Serial No. 75235807), Registration No. 2129014, is a abandoned US trademark filed on Feb 03, 1997 by Ilex Oncology, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

SOLUTIONS FOR ACCELERATED DRUG DEVELOPMENT (Reg. #2129014) is an abandoned US trademark that was filed in 1997 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 03, 1997

SERIAL

75235807

REG#

2129014

REGISTERED

Jan 13, 1998

Owner

Applicant

Ilex Oncology, Inc.

Entity

Corporation

State

Address

14785 Omicron Drive, San Antonio, TX, 782453217

Country

Attorney

NameEDWIN A GETZ

Law firm

EDWIN A GETZ GARDNER CARTON & DOUGLAS

Docket

ILX002USA

Address

321 N CLARK ST STE 3400, CHICAGO, IL 60610, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateFeb 03, 1997

Serial Number75235807

Registration No.2129014

Registration DateJan 13, 1998

Status DateOct 16, 2004

Published for OppositionOct 21, 1997

Mark TypeTypeset (words/letters/numbers)

Attorney DocketILX002USA

Status DescriptionDead and cancelled, Section 8

Filing Signals

FILED

1997

YEARS AGO

29y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: May 18, 1996

First use in commerce: May 18, 1996

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

6 events

CANCELLED SEC. 8 (6-YR)

Oct 16, 2004

CANCELLED SEC. 8 (6-YR)

REGISTERED-PRINCIPAL REGISTER

Jan 13, 1998

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Oct 21, 1997

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Sep 19, 1997

NOTICE OF PUBLICATION

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 23, 1997

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Aug 19, 1997

ASSIGNED TO EXAMINER

SOLUTIONS FOR ACCELERATED DRUG DEVELOPMENT

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Ilex Oncology, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by EDWIN A GETZ

Resources

Company